MVA-BN Brachyury: Phase I data
An open-label, dose-escalation, U.S. Phase I trial in 38 patients with advanced metastatic solid cancers or chordoma showed that 1, 2 and 4 injections of once-monthly 2x10 8 plaque-forming units (PFUs) subcutaneous MVA-BN Brachyury for...
